Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy.
Differential effects of partial and complete loss of TREM2 on microglial injury response and tauopathy.
复制标题
DOI:
10.1073/pnas.1811411115
复制
发表时间:
2018-10-02
影响因子:
11.1
通讯作者:
Gan L
中科院分区:
文献类型:
--
作者:
Sayed FA;Telpoukhovskaia M;Kodama L;Li Y;Zhou Y;Le D;Hauduc A;Ludwig C;Gao F;Clelland C;Zhan L;Cooper YA;Davalos D;Akassoglou K;Coppola G;Gan L
Late-onset Alzheimer’s disease is the most common form of dementia. A rare hemizygous variant in a microglial-expressed gene, Triggering Receptor Expressed on Myeloid Cells 2 (TREM2), significantly increases risk for late-onset Alzheimer’s disease. This variant is thought to cause loss of function, inducing TREM2 haploinsufficiency. The ramifications of TREM2 haploinsufficiency on microglial function and tau pathology are major gaps in the field. We find that, in contrast to the protective effects of complete TREM2 deficiency, TREM2 haploinsufficiency exacerbates tau pathology, inflammation, and atrophy at a late stage of disease in a mouse model of tauopathy. The differential effects of partial and complete loss of TREM2 are important considerations for TREM2-targeted therapeutic strategies. Alzheimer’s disease (AD), the most common form of dementia, is characterized by the abnormal accumulation of amyloid plaques and hyperphosphorylated tau aggregates, as well as microgliosis. Hemizygous missense variants in Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) are associated with elevated risk for developing late-onset AD. These variants are hypothesized to result in loss of function, mimicking TREM2 haploinsufficiency. However, the consequences of TREM2 haploinsufficiency on tau pathology and microglial function remain unknown. We report the effects of partial and complete loss of TREM2 on microglial function and tau-associated deficits. In vivo imaging revealed that microglia from aged TREM2-haploinsufficient mice show a greater impairment in their injury response compared with microglia from aged TREM2-KO mice. In transgenic mice expressing mutant human tau, TREM2 haploinsufficiency, but not complete loss of TREM2, increased tau pathology. In addition, whereas complete TREM2 deficiency protected against tau-mediated microglial activation and atrophy, TREM2 haploinsufficiency elevated expression of proinflammatory markers and exacerbated atrophy at a late stage of disease. The differential effects of partial and complete loss of TREM2 on microglial function and tau pathology provide important insights into the critical role of TREM2 in AD pathogenesis.
登录
查看更多内容
DOI:
10.1056/nejmoa1211851
发表时间:
2013-01-10
期刊:
The New England journal of medicine
影响因子:
--
作者:
Guerreiro R;Wojtas A;Bras J;Carrasquillo M;Rogaeva E;Majounie E;Cruchaga C;Sassi C;Kauwe JS;Younkin S;Hazrati L;Collinge J;Pocock J;Lashley T;Williams J;Lambert JC;Amouyel P;Goate A;Rademakers R;Morgan K;Powell J;St George-Hyslop P;Singleton A;Hardy J;Alzheimer Genetic Analysis Group
通讯作者:
Alzheimer Genetic Analysis Group
影响因子:
56.9
作者:
Nimmerjahn, A;Kirchhoff, F;Helmchen, F
通讯作者:
Helmchen, F
影响因子:
5.3
作者:
Jung, S;Aliberti, J;Littman, DR
通讯作者:
Littman, DR
影响因子:
15.1
作者:
Ulrich JD;Finn MB;Wang Y;Shen A;Mahan TE;Jiang H;Stewart FR;Piccio L;Colonna M;Holtzman DM
通讯作者:
Holtzman DM
DOI:
10.1073/pnas.1710311114
发表时间:
2017-10-24
影响因子:
11.1
作者:
Leyns CEG;Ulrich JD;Finn MB;Stewart FR;Koscal LJ;Remolina Serrano J;Robinson GO;Anderson E;Colonna M;Holtzman DM
通讯作者:
Holtzman DM